-
-
-
-
-
-
-
TScan Therapeutics, Inc. (TCRX) Tops Q1 EPS by 54c
-
-
-
-
-
-
-
TScan Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
TScan Therapeutics (TCRX) Announces CEO Transition
-
-
-
-
-
-
-
TScan Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
-
-
-
-
-
-
-
TScan Therapeutics Reports Full Year 2021 Financial Results and Highlights Key 2022 Priorities
-
-
-
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

